[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100473096":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":28,"locations":38,"responsibleParty":60,"collaborators":63,"id":67,"slug":11,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":11,"eligibilityCriteria":71,"healthyVolunteers":68,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":11,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":11,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Retina Foundation of the Southwest","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patch-free occlusion therapy","EXPERIMENTAL",null,[13],"Device: Patch-free occlusion therapy",{"label":15,"type":16,"description":11,"interventionNames":17},"Standard-of-care patching with an adhesive patch","ACTIVE_COMPARATOR",[18],"Device: Adhesive patch",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DEVICE","Use of filters in glasses to provide occlusion therapy",[9],{"type":21,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"Adhesive patch","Standard-of-care occlusion therapy with an adhesive patch",[15],[29,35],{"name":30,"role":31,"phone":32,"phoneExt":33,"email":34},"Eileen E Birch, PhD","CONTACT","2143633911","113","ebirch@retinafoundation.org",{"name":36,"role":31,"phone":32,"phoneExt":33,"email":37},"Reed M Jost, MS","reedjost@retinafoundation.org",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Retina Foundation","RECRUITING","Dallas","Texas","75231","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-96.80667,32.78306,{"lat":51,"lon":50},[54,56,58],{"name":36,"role":31,"phone":55,"phoneExt":33,"email":37},"214-363-3911",{"name":11,"role":31,"phone":11,"phoneExt":57,"email":34},"Birch",{"name":30,"role":59,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"type":59,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Eileen Birch","Senior Research Scientist",[64],{"name":65,"class":66},"National Eye Institute (NEI)","NIH","100473096",false,"NCT05440448","Patch-free Occlusion Therapy","Inclusion Criteria:\n\n* 3-12 years\n* male and female\n* strabismic, anisometropic, or combined mechanism amblyopia (visual acuity: 0.3-0.8 logMAR)\n* interocular visual acuity difference ≥0.3 logMAR\n* wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart\n* child's ophthalmologist and family willing to forgo standard patching treatment during the study\n\nExclusion Criteria:\n\n* Prematurity ≥8 wk\n* coexisting ocular or systemic disease\n* developmental delay\n* myopia \\> -3.00D","ALL","3 Years","12 Years",{"count":76,"type":77},68,"ESTIMATED","INTERVENTIONAL",[80],"NA","The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.",[83],"Amblyopia","2026-01-05",{"date":86,"type":87},"2026-01-07","ACTUAL",{"date":89,"type":87},"2024-04-22",{"date":91,"type":77},"2028-06-30",{"name":5,"class":6},1]